A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an immune checkpoint receptor targeted by cancer immunotherapy drugs, triggers a different response in rhesus macaques compared to humans. Read more
Medical News - Nov 25
WILMINGTON, DE & CINCINNATI, OH — Incyte (NASDAQ: INCY) and Enable Injections have formed a strategic partnership to co-develop and commercialize targeted cancer therapies using Enable’s enFuse® On-Body Delivery System, ... Read more
Mychesco - Nov 09
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global VEGFR-1 Inhibitors Market- (By Drug Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), By Application (Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, and Read more
Openpr.com - Nov 04
Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were linked to significantly longer survival in lung and melanoma cancer patients. The vaccines trigger a powerful type-I interferon response that primes tumors to become more respo... Read more
Medical News - Oct 24
Researchers fhave created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Read more
Medical News - Oct 23
The potential reasons that a Covid vaccine would help treat cancer are intriguing. Read more
Stat - Oct 19
